Not intended for US, Canada and UK-based media   Opinion based on Phase III data showing combination lowered risk of disease progression or death by 31% and improved objective response rate compared with …

source https://finance.yahoo.com/news/chmp-adopts-positive-opinion-bavencio-123400101.html?.tsrc=rss